GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $19,000 | -24.0% | 445 | -33.1% | 0.01% | 0.0% |
Q3 2021 | $25,000 | -3.8% | 665 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $26,000 | +8.3% | 665 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $24,000 | 0.0% | 665 | 0.0% | 0.01% | -10.0% |
Q4 2020 | $24,000 | +9.1% | 665 | +12.5% | 0.01% | -9.1% |
Q3 2020 | $22,000 | -8.3% | 591 | 0.0% | 0.01% | -15.4% |
Q2 2020 | $24,000 | +4.3% | 591 | 0.0% | 0.01% | -55.2% |
Q1 2020 | $23,000 | -28.1% | 591 | -21.8% | 0.03% | +38.1% |
Q3 2019 | $32,000 | +3.2% | 756 | 0.0% | 0.02% | 0.0% |
Q2 2019 | $31,000 | 0.0% | 756 | 0.0% | 0.02% | -4.5% |
Q1 2019 | $31,000 | +6.9% | 756 | 0.0% | 0.02% | -4.3% |
Q4 2018 | $29,000 | -6.5% | 756 | 0.0% | 0.02% | +9.5% |
Q3 2018 | $31,000 | +19.2% | 756 | +17.0% | 0.02% | +10.5% |
Q2 2018 | $26,000 | -60.0% | 646 | -61.2% | 0.02% | -60.4% |
Q1 2018 | $65,000 | – | 1,665 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |